Circ-FOXO3 inhibits triple-negative breast cancer growth and metastasis via regulating WHSC1-H3K36me2-Zeb2 axis

• Published in: Cellular signalling Vol. 117; p. 111079
• Main Authors: Chen, Danyang, Zeng, Shanshan, Qiu, Huisi, Yang, Mingqiang, Lin, Xin, Lv, Xinwu, Li, Pan, Weng, Shaojuan, Kou, Siyue, Luo, Kai, Liu, Zongcai, Yi, Yanmei, Liu, Hao
• Format: Journal Article
• Language: English
• Published: England Elsevier Inc 01.05.2024
• Subjects: circ-FOXO3; H3K36me2 modification; Triple-negative breast cancer; Tumor suppressor; WHSC1; PR; GEPIA; H3K36me2 modification; ChIP; circ-FOXO3; Tumor suppressor; CircRNA; EMT; ER; Triple-negative breast cancer; TSS; FISH; WHSC1; HER2; TNBC; RT-qPCR
• ISSN: 0898-6568; 1873-3913
• DOI: 10.1016/j.cellsig.2024.111079

Circular RNAs (circRNAs), a subclass of non-coding RNAs characterized by covalently closed continuous loops, play a key role in tumorigenesis and aggressiveness. However, the potential molecular mechanism of circRNAs in triple-negative breast cancer (TNBC) remains largely unknown. Exploring their roles and mechanisms in TNBC progression may help identify new diagnostic markers and therapeutic targets. In this study, we found that circ-FOXO3 was dramatically downregulated in TNBC tissues and blood samples from patients with TNBC. Notably, low circ-FOXO3 expression in TNBC tissues and bloods was associated with lymph node metastasis and unfavorable outcomes in patients with TNBC. Overexpression of circ-FOXO3 significantly inhibited the growth, invasion, and metastasis of TNBC cells both in vitro and in vivo. Moreover, we demonstrated that circ-FOXO3 was predominantly expressed in the cytoplasm and directly interacted with Wolf-Hirschhorn syndrome candidate 1 (WHSC1), thereby inhibiting WHSC1 nuclear localization and activity, resulting in the inhibition of H3K36me2 modifications at the Zeb2 promoter, ultimately inhibiting Zeb2 expression and halting TNBC growth and metastasis. Taken together, these results reveal the tumor-suppressive functions of circ-FOXO3 in inhibiting WHSC1-mediated H3K36me2 modification of Zeb2, suggesting that circ-FOXO3 could serve as a potential novel predictive prognostic biomarker and therapeutic target for TNBC. •Circ-FOXO3 expression is downregulated in TNBC tissues and cells.•Circ-FOXO3 suppresses TNBC cell proliferation and metastasis via Zeb2 inhibition.•Circ-FOXO3 inhibits TNBC progression by interacting with WHSC1 and inhibiting the WHSC1-H3K36me2-Zeb2 signaling pathway.